| Oct 4 |
Insider Trades: How to Find the Top Stocks
|
| Oct 4 |
DRI Healthcare Trust Buying Payment Streams Based On Gene-Editing Technology For US$57 Million
|
| Oct 4 |
3 Top Stocks That Could Still Rocket Higher in 2024
|
| Oct 4 |
2 Superior Growth Stocks That Are Screaming Buys Right Now
|
| Oct 3 |
Reasons that Lifted Vertex Pharmaceuticals Incorporated (VRTX) in Q2
|
| Oct 1 |
5 FDA decisions to watch in the fourth quarter
|
| Sep 30 |
Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing
|
| Sep 27 |
Vertex Pharmaceuticals presents vanzacaftor/tezacaftor/deutivacaftor data
|
| Sep 26 |
Wall Street Analysts See Vertex (VRTX) as a Buy: Should You Invest?
|
| Sep 26 |
Vertex Announces Health Canada Acceptance of New Drug Submission for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-in-Class Triple Combination Treatment for Cystic Fibrosis
|
